KR850007928A - 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 - Google Patents
세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 Download PDFInfo
- Publication number
- KR850007928A KR850007928A KR1019850002935A KR850002935A KR850007928A KR 850007928 A KR850007928 A KR 850007928A KR 1019850002935 A KR1019850002935 A KR 1019850002935A KR 850002935 A KR850002935 A KR 850002935A KR 850007928 A KR850007928 A KR 850007928A
- Authority
- KR
- South Korea
- Prior art keywords
- external preparation
- cephalosporin derivative
- derivative components
- preparing injectable
- components
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 실시예 1에서 얻은 분말 X선희석도(Cuka, 40KV, 45mA)를.
제2도는 실시예 1에서 얻은 목적물의 적외선흡수스펙틀(KBr)을 나타냄.
Claims (1)
- 하기 성분(ⅰ)과 (ⅱ)를 혼합하는 것을 특징으로 하는 성분(ⅰ) 및 (ⅱ)로 된 주사용 또는 외용제의 제조방법. (i) 7β-[2-(2-아미노티아졸-4-일)-(Z)-2-메톡시이미노아세트아미도]-3-[(1-메틸-1H-테트라졸-5-일)티오메틸] 세프-3-엠-4-카르복실산 1분자와 HCl 또는 HBr 2분의 1분자와의 결정성염. (ⅱ) 무독성의 알칼리 또는 알칼리염.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019850002935A KR890000787B1 (ko) | 1979-11-27 | 1985-04-30 | 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR7904155A KR880000181B1 (ko) | 1979-11-27 | 1979-11-27 | 세팔로스포린 유도체의 결정성염의 제조방법 |
KR1019850002935A KR890000787B1 (ko) | 1979-11-27 | 1985-04-30 | 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR7904155A Division KR880000181B1 (ko) | 1979-11-27 | 1979-11-27 | 세팔로스포린 유도체의 결정성염의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850007928A true KR850007928A (ko) | 1985-12-11 |
KR890000787B1 KR890000787B1 (ko) | 1989-04-07 |
Family
ID=19213669
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR7904155A KR880000181B1 (ko) | 1979-11-27 | 1979-11-27 | 세팔로스포린 유도체의 결정성염의 제조방법 |
KR1019850002935A KR890000787B1 (ko) | 1979-11-27 | 1985-04-30 | 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR7904155A KR880000181B1 (ko) | 1979-11-27 | 1979-11-27 | 세팔로스포린 유도체의 결정성염의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR880000181B1 (ko) |
-
1979
- 1979-11-27 KR KR7904155A patent/KR880000181B1/ko active
-
1985
- 1985-04-30 KR KR1019850002935A patent/KR890000787B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR880000181B1 (ko) | 1988-03-12 |
KR890000787B1 (ko) | 1989-04-07 |
KR830001295A (ko) | 1983-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU533708B2 (en) | 7-(2-alkoxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl) acetamido) cephalosporanic acid derivatives | |
FI881929A (fi) | Foerfarande foer framstaellning av foereningar vilka aer anvaendbara som mellanprodukter vid framstaellning av vinylcefalosporinderivat. | |
JPS5492987A (en) | Cephalosporanic acid derivative, its salt, or their preparation, and preventives and remedies for microbisms consisting mainly of them | |
ES412859A1 (es) | Un procedimiento para la preparacion de un derivado de 7- (alfa hidroxi-alfa-fenil) acetamido - 3 - (1 - metil - 1h - tetrazol - 5 - iltiometil) cefalosporina. | |
JPS6479188A (en) | 3,7-disubstituted-2-or 3-cephem-4-carboxylic acid compound or intermediate for salts thereof | |
KR880008811A (ko) | 동결건조 또는 침전된 세팔로스포린 양성이온 및 염 조성물 | |
KR840008372A (ko) | 무수결정성 셒타지딤의 제조방법 | |
KR850007928A (ko) | 세팔로스포린 유도체 성분의 주사용 또는 외용제의 제조방법 | |
KR830005235A (ko) | 결정성염의 제조방법 | |
FI792206A (fi) | Foerfarande foer framstaellning av nya oxadiazolopyrimidinderivat | |
JPS54138590A (en) | 7-methoxycephalosporin compound, its preparation, and anti-bacterial agent containing the same | |
ES8100299A1 (es) | Un procedimiento para preparar un semi-acido-sal cristalino de un derivado de cefalosporina | |
IE780453L (en) | Preparation of cephalosporin derivatives. | |
KR860000304A (ko) | 세프타지딤 중간체의 제조방법 | |
SE8701193D0 (sv) | Nya mellanprodukter for framstellning av 2-(2-aminotiazol-4-yl)-glyoxylsyraderivat eller ett salt derav samt forfarande for framstellning av mellanprodukterna | |
GB1525626A (en) | Tetrazolethiomethyl cephalosporin compounds | |
KR850007927A (ko) | 세팔로스포린 유도체 결정성염의 제조방법 | |
US3573298A (en) | N-hydroxyethylamino- and n-morpholino-dithiocarboxylated cephalosporins | |
JPS5515454A (en) | Novel cephalosporin derivative | |
KR860003264A (ko) | 세팔로스포린 화합물의 제조방법 | |
KR850007429A (ko) | 세팔로스포린 화합물의 제조방법 | |
KR830007691A (ko) | 아실유도체의 제조방법 | |
JPS52125184A (en) | Novel cephalosporin compounds | |
JPS55149295A (en) | Novel cephalosporin compound and its preparation | |
CH610329A5 (en) | Process for the preparation of stable crystalline salts of cephalosporins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
J2X1 | Appeal (before the patent court) |
Free format text: INVALIDATION |
|
FPAY | Annual fee payment |
Payment date: 19940315 Year of fee payment: 6 |
|
EXPY | Expiration of term |